TD Cowen Maintains Buy on Boston Scientific, Lowers Price Target to $56
Benzinga Newsdesk 3 months ago
Analyst RatingsNewsPrice TargetHot
TD Cowen analyst Joshua Jennings maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $61 to $56.
TD Cowen analyst Joshua Jennings maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $61 to $56.